VIR
Vir Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.60
−2.93%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 33.43x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.83x
- Price / sales
- 5.92x
- Price / cash flow
- -5.36x
Enterprise value
- Enterprise value
- $1.4B
- EV / sales
- 4.48x
- EV / EBITDA
- -5.56x
- EV / EBIT
- -5.04x
- Market cap
- $1.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026